Affitech A/S - Product Pipeline Review - Q4 2010

Global Markets Direct, December 2010, Pages: 56

Affitech A/S – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Affitech A/S - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Affitech A/S - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Affitech A/S human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Affitech A/S with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Affitech A/S’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Affitech A/S’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Affitech A/S in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Affitech A/S’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Affitech A/S.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Affitech A/S and identify potential opportunities in those areas.

List of Tables
List of Figures
Affitech A/S Snapshot
Affitech A/S Overview
Key Information
Key Facts
Affitech A/S – Research and Development Overview
Key Therapeutic Areas
Affitech A/S – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Affitech A/S – Pipeline Products Glance
Affitech A/S Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Affitech A/S–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Affitech A/S – Drug Profiles
PX 104.1
Product Description
Mechanism of Action
R&D Progress
EP1043 + EP1090
Product Description
Mechanism of Action
R&D Progress
EP1300
Product Description
Mechanism of Action
R&D Progress
PX 103.2
Product Description
Mechanism of Action
R&D Progress
AT001
Product Description
Mechanism of Action
R&D Progress
AT002
Product Description
Mechanism of Action
R&D Progress
AT003
Product Description
Mechanism of Action
R&D Progress
AT004
Product Description
Mechanism of Action
R&D Progress
AT005
Product Description
Mechanism of Action
R&D Progress
AT006
Product Description
Mechanism of Action
R&D Progress
AT008
Product Description
Mechanism of Action
R&D Progress
AT009
Product Description
Mechanism of Action
R&D Progress
EP1400
Product Description
Mechanism of Action
R&D Progress
PGN635
Product Description
Mechanism of Action
R&D Progress
AT010
Product Description
Mechanism of Action
R&D Progress
Affitech A/S – Pipeline Analysis
Affitech A/S – Pipeline Products by Therapeutic Class
Affitech A/S Pipeline Products By Target
Affitech A/S – Pipeline Products by Route of Administration
Affitech A/S – Pipeline Products by Molecule Type
Affitech A/S – Recent Pipeline Updates
Affitech A/S - Dormant Projects
Affitech A/S – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Sep 06, 2007: Pharmexa Presents New Data from Two Experimental Flu Vaccines on International Vaccine Conference
Aug 29, 2006: Pharmexa Receives Approval To Initiate Phase Ib Study With HIV Vaccine In The US
Financial Deals Landscape
Affitech A/S, Deals Volume Summary, 2004 to YTD 2010
Affitech A/S, Deals Summary By Region, 2004 to YTD 2010
Affitech A/S, Deals Summary, 2004 to YTD 2010
Affitech A/S Detailed Deal Summary
Acquisition
Pharmexa Acquires Affitech
Affitech Enters Into Discovery and Development Agreement With Omeros
ProBioGen Enters Into Co-Development Agreement With Affitech
Licensing Agreements
Peregrine Pharmaceuticals Enters Into License Agreement With Affitech
Pharmexa Enters Into Licensing Agreement with Affitech
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• eLEARNING - Global Strategic Business Report
• Charter Schools - Global Outlook
• Aerospace and Defense Industry - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Sports and Fitness Nutrition - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• International Military and Government Helicopter Survey
• Defense Robotics - Global Strategic Business Report
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans